13F HOLDINGS REPORT
GILEAD SCIENCES, INC.
Quarter ended Q4 2024 · Filed February 13, 2025 · Accession 0001123292-25-000079
Total Value
$1.55B
Positions
16
Other Managers
1
Confidential Omitted
No
Holdings (16)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ARCELLX INC | ACLX | 6,720,803 | $515.4M | 33.23% |
| 2 | GALAPAGOS NV | GLPGF | 16,707,477 | $461.7M | 29.77% |
| 3 | ARCUS BIOSCIENCES INC | RCUS | 30,061,124 | $447.6M | 28.86% |
| 4 | ASSEMBLY BIOSCIENCES INC | ASMB | 2,209,471 | $34.9M | 2.25% |
| 5 | MERUS N V | N5749R100 | 452,527 | $19.0M | 1.23% |
| 6 | KYVERNA THERAPEUTICS INC | KYTX | 4,126,119 | $15.4M | 0.99% |
| 7 | LEAP THERAPEUTICS INC | CYPH | 5,319,148 | $15.3M | 0.99% |
| 8 | TANGO THERAPEUTICS INC | TNGX | 4,854,443 | $15.0M | 0.97% |
| 9 | XILIO THERAPEUTICS INC | XLO | 9,105,451 | $8.7M | 0.56% |
| 10 | ALLOVIR INC | 019818103 | 16,635,286 | $7.0M | 0.45% |
| 11 | HOOKIPA PHARMA INC | HOOK | 1,875,945 | $3.8M | 0.24% |
| 12 | IKENA ONCOLOGY INC | 45175G108 | 2,008,338 | $3.3M | 0.21% |
| 13 | ALLOGENE THERAPEUTICS INC | ALLO | 1,156,689 | $2.5M | 0.16% |
| 14 | BARINTHUS BIOTHERAPEUTICS PL | BRNS | 620,351 | $749,384 | 0.05% |
| 15 | AGENUS INC | AGEN | 231,663 | $634,757 | 0.04% |
| 16 | KRONOS BIO INC | 50107A104 | 188,567 | $179,139 | 0.01% |